A combination of two antiviral compounds may be a promising alternative to Paxlovid when treating COVID-19 in ...
By Nicholas Van Sickles University of Kentucky A safe and effective medication designed to prevent mild-to-moderate COVID-19 ...
Study findings that reveal a sensitivity of 47% for COVID-19 rapid antigen tests (RATs) compared with reverse-transcription ...
Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, ...
A potential treatment for COVID-19 may have been hiding in our medicine cabinets, a new study in PNAS has found ...
Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year over year, beating the consensus of $0.54.
There are new Canadian recommendations for who should actually get Paxlovid at this point, guided by a growing body of ...
But if Paxlovid is initiated before 3 days, the risk of viral rebound is significantly increased with no improvement in ...
Researchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit ...
Pfizer lifted its annual profit forecast on Wednesday, and reported first-quarter results that topped Wall Street estimates ...
(Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, boosted by cost cutting efforts and stronger-than-expected sales of ...
(Reuters) -Pfizer lifted its annual profit forecast, banking on cost cuts, a smaller-than-feared drop in sales for its COVID ...